Medicinova Inc. buy melinda
Start price
15.10.17
/
50%
€6.09
Target price
26.10.17
€6.31
Performance (%)
7.41%
End price
26.10.17
€6.54
Summary
This prediction ended on 26.10.17 with a price of €6.54. With a performance of 7.41%, the BUY prediction by melinda for Medicinova Inc. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Medicinova Inc. | - | - | - | - |
| iShares Core DAX® | -0.975% | -4.716% | 4.787% | 53.022% |
| iShares Nasdaq 100 | 1.163% | 1.881% | 20.234% | 95.411% |
| iShares Nikkei 225® | -1.593% | -5.385% | 31.353% | 54.646% |
| iShares S&P 500 | -0.278% | 0.327% | 13.911% | 66.550% |
Comments by melinda for this prediction
In the thread Medicinova Inc. diskutieren
Progredienter Multipler Sklerose (progressive MS)
Die erste Zeile der Daten aus dem Phase - 2b wird 28. Oktober präsentiert wird 2017 auf der gemeinsamen Sitzung ECTRIMS - ACTRIMS.